![Robert Polke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Polke
Nessuna posizione attualmente
Profilo
Robert Polke worked as an Operations Director at Circa Pharmaceuticals, Inc. and as a Supervisor-Solid Dosage Manufacturing Operations at Pfizer Inc. He then worked as a VP-Manufacturing & Technical Operations at Endo Generics Holdings, Inc. from 2000 to 2011.
After that, he worked as a Vice President-Operations at Indigo Pharmaceuticals, Inc. and as an Executive VP & Global Head-Operations at Endo International Plc.
He also worked as a Chief Operating Officer at BML Pharmaceuticals, Inc. and as a Senior VP-Manufacturing & Technical Operations at Par Pharmaceutical, Inc. Mr. Polke received his undergraduate degree and MBA from St. John's University.
Precedenti posizioni note di Robert Polke
Società | Posizione | Fine |
---|---|---|
PFIZER, INC. | Corporate Officer/Principal | - |
ENDO INTERNATIONAL PLC | Direttore operativo | - |
Par Pharmaceutical, Inc.
![]() Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | - |
Circa Pharmaceuticals, Inc. | Direttore operativo | - |
BML Pharmaceuticals, Inc.
![]() BML Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services BML Pharmaceuticals, Inc. provides research and develops proprietary prescriptive pharmaceutical products in the area of cancer treatment. The company is based in Chadds Ford, PA. | Direttore operativo | - |
Formazione di Robert Polke
St. John's University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
PFIZER, INC. | Health Technology |
Aziende private | 6 |
---|---|
Endo Generics Holdings, Inc.
![]() Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Indigo Pharmaceuticals, Inc.
![]() Indigo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indigo Pharmaceuticals, Inc. manufactures pharmaceutical products. It mainly focuses on the development of new treatments for cardiovascular diseases, such as peripheral arterial disease. The company was founded in 2007 and is headquartered in New York, NY. | Health Technology |
BML Pharmaceuticals, Inc.
![]() BML Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services BML Pharmaceuticals, Inc. provides research and develops proprietary prescriptive pharmaceutical products in the area of cancer treatment. The company is based in Chadds Ford, PA. | Commercial Services |
Circa Pharmaceuticals, Inc. | Health Technology |
Par Pharmaceutical, Inc.
![]() Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Endo International Plc
![]() Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Robert Polke